Found: 13
Select item for more details and to access through your institution.
Unusual cytological features in multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 957, doi. 10.1002/ajh.24428
- By:
- Publication type:
- Article
Study Some Biochemical Parameters in Beta Thalassemia Major Patients in Males and Females Adults in Baghdad.
- Published in:
- Indian Journal of Forensic Medicine & Toxicology, 2020, v. 14, n. 4, p. 2249, doi. 10.37506/ijfmt.v14i4.11887
- By:
- Publication type:
- Article
Evaluation of Natural killer activated receptor NKG2D, Inhibitory receptor KIR2DL1 and soluble ligand MICA in Iraqi patients of Acute myeloid leukemia.
- Published in:
- Journal of Pharmaceutical Negative Results, 2022, v. 13, p. 148, doi. 10.47750/pnr.2022.13.S05.21
- By:
- Publication type:
- Article
Do We Need Local Guidelines for the Diagnosis and Management of Immune Thrombocytopenia in Iraq?
- Published in:
- Journal of Applied Hematology, 2023, v. 14, n. 2, p. 146, doi. 10.4103/joah.joah_7_23
- By:
- Publication type:
- Article
Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy.
- Published in:
- Immunogenetics, 2023, v. 75, n. 2, p. 145, doi. 10.1007/s00251-022-01291-4
- By:
- Publication type:
- Article
IMPACT OF PROGRAMMED DEATH 1 EXPRESSION IN CHRONIC MYELOID LEUKEMIA AT DIFFERENT MOLECULAR RESPONSES TO IMATINIB MESYLATE TREATMENT.
- Published in:
- Biochemical & Cellular Archives, 2021, v. 21, n. 1, p. 671
- By:
- Publication type:
- Article
STUDY OF REPRODUCTIVE HORMONAL CHANGES IN BETATHALASSEMIA MAJOR PATIENTS IN MALES AND FEMALES.
- Published in:
- Biochemical & Cellular Archives, 2020, v. 20, n. 1, p. 1949, doi. 10.35124/bca.2020.20.1.1949
- By:
- Publication type:
- Article
Treatment outcome of the tyrosine kinase inhibitor (bosutinib) in previously treated chronic myeloid leukemia patients (sample of Iraqi patients).
- Published in:
- Iraqi Journal of Hematology, 2024, v. 13, n. 1, p. 12, doi. 10.4103/ijh.ijh_59_23
- By:
- Publication type:
- Article
The Role of Immune Check Point Gene Expression of Pd-1 and Tim-3 in Patients with Acute Myeloid Leukemia.
- Published in:
- Al-Mustansiriyah Journal of Science, 2024, v. 35, n. 1, p. 27, doi. 10.23851/mjs.v35i1.1418
- By:
- Publication type:
- Article
The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients.
- Published in:
- Al-Mustansiriyah Journal of Science, 2023, v. 34, n. 1, p. 16, doi. 10.23851/mjs.v34i1.1224
- By:
- Publication type:
- Article
Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate with Different BCR-ABL Transcripts Levels Response.
- Published in:
- Medico-Legal Update, 2021, v. 21, n. 1, p. 949, doi. 10.37506/mlu.v21i1.2438
- By:
- Publication type:
- Article
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3234, doi. 10.3390/ijms25063234
- By:
- Publication type:
- Article
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 12, p. 10374, doi. 10.3390/ijms241210374
- By:
- Publication type:
- Article